E. Mearns

发表

Economic analysis and budget impact of clostridial collagenase ointment compared with medicinal honey for treatment of pressure ulcers in the US

A. Gilligan, Jeffrey D. Miller, E. Mearns, 2017, ClinicoEconomics and outcomes research : CEOR.

Measures of vitamin K antagonist control reported in atrial fibrillation and venous thromboembolism studies: a systematic review

C. Coleman, E. Mearns, Jessica Hawthorne, 2014, BMJ Open.

Common flaws exist in published cost-effectiveness models of pharmacologic stroke prevention in atrial fibrillation.

C. White, J. Kluger, W. Baker, 2014, Journal of clinical epidemiology.

Comparative Efficacy and Safety of Antidiabetic Drug Regimens Added to Metformin Monotherapy in Patients with Type 2 Diabetes: A Network Meta-Analysis

C. White, D. Sobieraj, C. Coleman, 2015, PloS one.

Prognostic accuracy of clinical prediction rules for early post-pulmonary embolism all-cause mortality: a bivariate meta-analysis.

Adrian V. Hernández, C. Coleman, M. Parker, 2015, Chest.

Index clinical manifestation of venous thromboembolism predicts early recurrence type and frequency: a meta‐analysis of randomized controlled trials

C. Coleman, E. Mearns, C. Kohn, 2015, Journal of thrombosis and haemostasis : JTH.

Comparative efficacy and safety of antidiabetic drug regimens added to stable and inadequate metformin and thiazolidinedione therapy in type 2 diabetes

D. Sobieraj, C. Coleman, E. Mearns, 2015, International journal of clinical practice.

Efficacy and safety of antihyperglycaemic drug regimens added to metformin and sulphonylurea therapy in Type 2 diabetes: a network meta‐analysis

S. Lemieux, C. White, C. Coleman, 2015, Diabetic medicine : a journal of the British Diabetic Association.

Systematic Literature Review of the Economic Burden of Celiac Disease

D. Sanders, D. Leffler, B. Lebwohl, 2018, PharmacoEconomics.

Diagnosis and Treatment Patterns in Celiac Disease

D. Sanders, D. Leffler, B. Lebwohl, 2019, Digestive Diseases and Sciences.

Meta-analysis to assess the quality of international normalized ratio control and associated outcomes in venous thromboembolism patients.

J. Schein, C. White, C. Coleman, 2014, Thrombosis research.

A Review of US Drug Costs Relevant to Medicare, Medicaid, and Commercial Insurers Post-Affordable Care Act Enactment, 2010–2016

L. Pizzi, F. Vogenberg, E. Mearns, 2017, PharmacoEconomics.

Plasma Catecholamine Profile of Subarachnoid Hemorrhage Patients with Neurogenic Cardiomyopathy

A. Walters, M. DeCaro, E. Mearns, 2015, Cerebrovascular Diseases Extra.

Comparative cost and clinical effectiveness of clostridial collagenase ointment for chronic dermal ulcers.

C. Fife, M. Carter, A. Gilligan, 2018, Journal of comparative effectiveness research.

Cost‐Effectiveness of High‐Dose Edoxaban Compared with Adjusted‐Dose Warfarin for Stroke Prevention in Non–Valvular Atrial Fibrillation Patients

C. White, C. Coleman, E. Mearns, 2016, Pharmacotherapy.

Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regression

J. Schein, C. White, C. Coleman, 2014, Thrombosis Journal.

Gastrointestinal adverse events with combination of checkpoint inhibitors in advanced melanoma: a systematic review

A. Galaznik, E. Mearns, J. Bell, 2018, Melanoma management.

Neurological Manifestations of Neuropathy and Ataxia in Celiac Disease: A Systematic Review

D. Sanders, D. Leffler, B. Lebwohl, 2019, Nutrients.

Vitamin K antagonist use: evidence of the difficulty of achieving and maintaining target INR range and subsequent consequences

W. Nelson, J. Schein, C. White, 2016, Thrombosis Journal.

Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regression

J. Schein, C. Coleman, E. Mearns, 2014, Thrombosis Journal.